Data reveals gaps in dedicated paediatric continence provision

    Insights

    Clinical Commissioning Groups (CCGs) are not improving children's continence care. The Paediatric Continence Forum (PCF) highlights this failure in essential child health services.

    Area of Science:

    • Pediatric Healthcare Management
    • Public Health Policy
    • Child Development & Wellbeing

    Background:

    • Clinical Commissioning Groups (CCGs) are responsible for planning and commissioning health services for their local areas.
    • Children's continence care is a vital aspect of pediatric health, impacting quality of life and school attendance.
    • The Paediatric Continence Forum (PCF) is a key stakeholder group advocating for improved continence services for children.

    Discussion:

    • Evidence suggests CCGs are not effectively prioritizing or driving improvements in pediatric continence services.
    • This lack of progress may stem from inadequate funding, insufficient strategic focus, or a lack of specialized commissioning expertise.
    • The PCF's findings indicate a systemic issue in how CCGs are addressing this specific area of child health.

    Key Insights:

    • CCGs are underperforming in enhancing children's continence care.
    • The Paediatric Continence Forum (PCF) has identified significant shortcomings in current commissioning practices.
    • Urgent attention is needed to address the deficiencies in pediatric continence service provision.

    Outlook:

    • Future efforts must focus on enhancing CCG accountability and performance in pediatric continence care.
    • Developing clear national guidelines and performance metrics for continence services is crucial.
    • Increased collaboration between CCGs, healthcare providers, and patient advocacy groups like the PCF is essential for progress.

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    398
    Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

    Parentral Nutrition: Centeral and Peripheral Parental Nutrition

    Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
    PN can be administered through two primary routes:
    1. Central Parenteral Nutrition (CPN):
    CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
    1.9K
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    924
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    998
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    542
    Inflammatory Bowel Disease V: Surgical Management01:21

    Inflammatory Bowel Disease V: Surgical Management

    Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
    Here are some common surgical interventions for IBD:
    903